EUVIMEDEUVIMED entdecken
Crossref

Polysialic-emodin self-assembled nanoparticles synergize with PD-1 inhibitors to enhance tumor immunotherapy

Mengdan Shen, Xi Han, Xixi Li, Jiayun Ji, Shunyao Zhu, Beihua Xu, Senlin Shi, Ting Zhang

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.115248 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Mengdan Shen und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China. Hauptthemen laut MEDLINE: Nanoparticles, Programmed Cell Death 1 Receptor, Immunotherapy, Immune Checkpoint Inhibitors. Die Arbeit nennt 57 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, emodin (ED) and polysialic acid (PSA) were synthesized into a compound called PSA-ED. The PSA-ED self-assembled into nanoparticles (PE-NS) using a nano-precipitation method. According to the results of particle size analyzer, the particle size of PE-NS was 180.7 ± 1.60 nm, the polydispersity index (PDI) was 0.263 ± 0.090, and the ζ potential was -17.1 ± 0.9 mV. In vitro cellular experiments confirmed that compared to free emodin, PE-NS exhibited significantly higher cellular uptake in RAW264.7 cells. In addition, in vivo imaging demonstrated enhanced fluorescence accumulation in tumors. This indicated that PE-NS possesses the ability to effectively target tumor-associated macrophages (TAMs). We conducted experiments using a mouse model of the B16F10 tumor, treating the mice with PD-1 antibody, PE-NS, and various doses of PE-NS + anti-PD-1 antibody, and compared them with untreated controls. In the PE-NS and anti-PD-1 antibody combination therapy group, there was a notable decrease in the proportion of M2-TAMs and CD4 + Fop3+ T cells, alongside a significant increase in the proportion of M1-TAMs and CD8+ T cells, resulting in an increased tumor inhibition rate. The combination of PE-NS and anti-PD-1 antibody exhibited synergistic antitumor activity, enhancing the effectiveness of PD-1 checkpoint blockers in the mouse melanoma models. In conclusion, the combination of PE-NS and anti-PD-1 antibody immunotherapy holds great promise in improving the therapeutic effects of melanoma treatment and may offer a novel strategy for clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesProgrammed Cell Death 1 ReceptorImmunotherapyImmune Checkpoint InhibitorsMelanoma, ExperimentalSialic AcidsEmodinAnimalsMiceRAW 264.7 CellsMice, Inbred C57BLCell Line, TumorHumansDrug SynergismFemaleTumor-Associated Macrophages

Stichwörter der Autor:innen

Combined anti-tumor therapyEmodinPD-1 inhibitorPolysialic acidT-cell activityTumor-associated macrophages remodeling

Substanzen

Programmed Cell Death 1 ReceptorImmune Checkpoint InhibitorsSialic Acidspolysialic acidEmodinPdcd1 protein, mouse

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
  • School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou 310053, China.
  • School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China. Electronic address: Zhangting55@zcmu.edu.cn.

Förderung

  • Natural Science Foundation of Zhejiang Province
  • National Natural Science Foundation of China

Zitieren

APA

Shen, M., Han, X., Li, X., Ji, J., Zhu, S., Xu, B., Shi, S., & Zhang, T. (2025). Polysialic-emodin self-assembled nanoparticles synergize with PD-1 inhibitors to enhance tumor immunotherapy. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115248

Vancouver

Shen M, Han X, Li X, Ji J, Zhu S, Xu B, et al. Polysialic-emodin self-assembled nanoparticles synergize with PD-1 inhibitors to enhance tumor immunotherapy. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115248

BibTeX
@article{Shen2025,
  author = {Shen, Mengdan and Han, Xi and Li, Xixi and Ji, Jiayun and Zhu, Shunyao and Xu, Beihua and Shi, Senlin and Zhang, Ting},
  title = {Polysialic-emodin self-assembled nanoparticles synergize with PD-1 inhibitors to enhance tumor immunotherapy},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.115248}
}
Kostenlos starten →